Free Trial

Accuray (ARAY) Competitors

Accuray logo
$1.70 -0.06 (-3.41%)
Closing price 10/14/2025 04:00 PM Eastern
Extended Trading
$1.85 +0.15 (+8.59%)
As of 05:20 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ARAY vs. OFIX, ANGO, SRDX, RMTI, ABT, ISRG, BSX, SYK, MDT, and BDX

Should you be buying Accuray stock or one of its competitors? The main competitors of Accuray include Orthofix Medical (OFIX), AngioDynamics (ANGO), Surmodics (SRDX), Rockwell Medical (RMTI), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), and Becton, Dickinson and Company (BDX). These companies are all part of the "health care equipment" industry.

Accuray vs. Its Competitors

Orthofix Medical (NASDAQ:OFIX) and Accuray (NASDAQ:ARAY) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, dividends, profitability, analyst recommendations, institutional ownership and risk.

Accuray has lower revenue, but higher earnings than Orthofix Medical. Accuray is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Orthofix Medical$799.49M0.73-$126M-$3.17-4.67
Accuray$458.51M0.42-$1.59M-$0.02-85.00

Orthofix Medical has a beta of 0.89, suggesting that its share price is 11% less volatile than the S&P 500. Comparatively, Accuray has a beta of 1.31, suggesting that its share price is 31% more volatile than the S&P 500.

89.8% of Orthofix Medical shares are held by institutional investors. Comparatively, 64.1% of Accuray shares are held by institutional investors. 1.3% of Orthofix Medical shares are held by insiders. Comparatively, 4.4% of Accuray shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Orthofix Medical and Orthofix Medical both had 5 articles in the media. Orthofix Medical's average media sentiment score of 0.69 beat Accuray's score of 0.50 indicating that Orthofix Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Orthofix Medical
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Accuray
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Orthofix Medical presently has a consensus target price of $21.75, indicating a potential upside of 47.06%. Accuray has a consensus target price of $5.00, indicating a potential upside of 194.12%. Given Accuray's higher probable upside, analysts clearly believe Accuray is more favorable than Orthofix Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Orthofix Medical
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50
Accuray
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Accuray has a net margin of -0.35% compared to Orthofix Medical's net margin of -15.29%. Accuray's return on equity of -4.92% beat Orthofix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Orthofix Medical-15.29% -25.43% -14.46%
Accuray -0.35%-4.92%-0.58%

Summary

Accuray beats Orthofix Medical on 8 of the 15 factors compared between the two stocks.

Get Accuray News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARAY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ARAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ARAY vs. The Competition

MetricAccurayMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$198.39M$7.00B$6.04B$10.51B
Dividend YieldN/A1.18%5.73%4.80%
P/E Ratio-85.0026.7984.7027.24
Price / Sales0.4227.55514.31200.41
Price / Cash39.4821.5837.5761.53
Price / Book2.365.1812.316.74
Net Income-$1.59M$178.09M$3.32B$276.59M
7 Day Performance1.19%-2.86%-1.33%-0.47%
1 Month Performance5.59%5.12%8.13%7.47%
1 Year Performance-9.09%5.21%73.08%34.58%

Accuray Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ARAY
Accuray
4.444 of 5 stars
$1.70
-3.4%
$5.00
+194.1%
-5.6%$198.39M$458.51M-85.001,040Gap Up
OFIX
Orthofix Medical
2.9059 of 5 stars
$14.17
-3.0%
$21.75
+53.5%
-8.1%$577.01M$799.49M-4.471,616
ANGO
AngioDynamics
4.2059 of 5 stars
$11.26
-3.3%
$19.33
+71.7%
+76.9%$479.57M$292.50M-14.44760
SRDX
Surmodics
4.5608 of 5 stars
$28.70
-1.4%
$43.00
+49.8%
-28.0%$416.35M$126.08M-23.33450News Coverage
Positive News
RMTI
Rockwell Medical
3.4787 of 5 stars
$1.21
-0.8%
$4.00
+230.6%
-65.6%$42.01M$101.49M-20.17300
ABT
Abbott Laboratories
4.9564 of 5 stars
$133.63
-0.7%
$145.39
+8.8%
+13.6%$234.25B$41.95B16.75114,000Positive News
Analyst Forecast
ISRG
Intuitive Surgical
4.9419 of 5 stars
$449.69
-0.6%
$594.19
+32.1%
-10.5%$162.16B$8.35B62.7215,638Trending News
Upcoming Earnings
Analyst Forecast
BSX
Boston Scientific
4.9048 of 5 stars
$96.73
-0.6%
$120.79
+24.9%
+9.9%$144.20B$16.75B57.5853,000Positive News
Upcoming Earnings
SYK
Stryker
4.9651 of 5 stars
$365.99
-1.2%
$430.33
+17.6%
+2.9%$141.64B$22.60B48.4853,000Positive News
Analyst Forecast
MDT
Medtronic
4.8568 of 5 stars
$98.46
+0.8%
$100.94
+2.5%
+7.3%$125.32B$33.54B27.1295,000Positive News
BDX
Becton, Dickinson and Company
4.9455 of 5 stars
$191.94
-0.9%
$205.40
+7.0%
-21.5%$55.49B$20.18B34.5274,000Positive News

Related Companies and Tools


This page (NASDAQ:ARAY) was last updated on 10/15/2025 by MarketBeat.com Staff
From Our Partners